Tern Plc secures extension on £120,000 loan balance

TERN

Tern Plc (LON:TERN), the investment company specialising in supporting high growth, early-stage, disruptive Internet of Things technology businesses, has announced that the repayment date of the loan facility agreement originally announced on 12 June 2023 has been extended, with the agreement of the Loan provider, to 11 September 2026.  The Board considers that the extension gives the Company greater negotiating flexibility in relation to funding the future capital requirements of its investee companies.  Since being entered into the Loan has been varied twice previously, as announced on 4 September 2024 and 15 September 2025.

The Company has agreed to make a payment of £38,432.88 to the Loan provider as a partial repayment of the outstanding Loan balance and accrued interest, plus a Loan extension fee of £6,000. Following these payments £120,000 will remain outstanding under the Loan and this amount, plus accrued interest at a rate of 1.00% per calendar month, will be repayable by the Company on or before 11 September 2026.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

GLP-1 drugs linked to emerging research into mental health and addiction

Research into GLP-1 medicines is expanding beyond weight loss, with studies examining potential links to depression, cognitive function, alcohol...

Talking Medicines examines emerging links between GLP-1 drugs and mental health

Researchers are investigating the potential links between GLP-1 medicines and mental health, with early findings prompting further studies into...

Tern invests £78,000 in Device Authority through 8% convertible loan notes

Tern Plc has committed approximately £78,000 to new convertible loan notes issued by Device Authority, which carry 8% annual...

Device Authority highlights security risks as AI begins controlling physical machines

Device Authority examines the security risks of AI-controlled machinery and the role of device identity, authentication and access controls...

Talking Medicines targets better pharmaceutical launch results through message analysis

Talking Medicines' Message Resonance Score measures doctors' understanding of pharmaceutical messaging to help companies improve launch strategies....

Device Authority addresses security risks as AI takes control of physical machines

Device Authority's KeyScaler platform supports secure AI-driven automation by helping organisations authenticate connected machines, protect device identities and control...

Search